<div id="readability-page-1"><p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 23,965 shares of the firm's stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $397,579.35. Following the completion of the sale, the insider owned 477,183 shares in the company, valued at $7,916,465.97. This represents a 4.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through this link.</p><ul><li>5 Small Cap Stocks With Explosive Upside Potential</li></ul><p>Mario Schlosser also recently made the following trade(s): </p><ul><li>On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14. </li><li>On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. </li></ul><h2>Oscar Health Stock Performance</h2><p>Shares of OSCR stock traded up $0.07 during mid-day trading on Thursday, reaching $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The firm has a market cap of $4.55 billion, a PE ratio of -15.33 and a beta of 1.88. The firm's 50 day simple moving average is $18.08 and its 200 day simple moving average is $16.93. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. </p><p>Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to analysts' expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health's quarterly revenue was up 23.2% compared to the same quarter last year. During the same period last year, the business earned ($0.22) earnings per share.  On average, analysts forecast that  Oscar Health, Inc. will post 0.69 EPS for the current year. </p><h2>Institutional Investors Weigh In On Oscar Health</h2><p>A number of institutional investors have recently made changes to their positions in OSCR. American Century Companies Inc. increased its position in  Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after buying an additional 2,495,691 shares during the last quarter.  Nuveen LLC acquired a new position in shares of  Oscar Health during the 1st quarter worth approximately $29,684,000.  Farallon Capital Management LLC increased its holdings in shares of  Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after acquiring an additional 2,163,000 shares during the last quarter.  Thrive Capital Management LLC raised its stake in  Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the period.  Finally, State of Michigan Retirement System bought a new stake in  Oscar Health in the 3rd quarter valued at $27,448,000. 75.70% of the stock is owned by institutional investors and hedge funds. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several research analysts recently issued reports on the stock. Wells Fargo &amp; Company dropped their price target on shares of Oscar Health from $14.00 to $11.00 and set an &#34;underweight&#34; rating for the company in a research report on Thursday, November 13th. The Goldman Sachs Group assumed coverage on Oscar Health in a report on Tuesday, October 14th. They issued a &#34;neutral&#34; rating and a $17.00 target price for the company. Piper Sandler raised Oscar Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and boosted their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. UBS Group upped their price target on Oscar Health from $11.00 to $12.00 and gave the company a &#34;sell&#34; rating in a research report on Friday, November 7th. Finally, Barclays increased their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an &#34;underweight&#34; rating in a research note on Monday, November 10th. One analyst  has rated the stock with a Buy rating, five have issued  a Hold rating and five have issued  a Sell rating to the company. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of &#34;Reduce&#34; and a consensus price target of $14.86.</p><p><b>Get Our Latest Research Report on OSCR</b></p><h2>Oscar Health Company Profile</h2> (Get Free Report)<p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Oscar Health</li><li>Stock Market Sectors: What Are They and How Many Are There? </li><li>Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF</li><li>Insider Trading - What You Need to Know</li><li>Strong Quarter, Weak Reaction: Why GitLab Shares Dropped</li><li>ESG Stocks, What Investors Should Know</li><li>3 Signs Tesla Is Starting December on the Front Foot</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2><p>Before you consider Oscar Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p><p>While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

OSCR

<p>Oscar Health insider Mario Schlosser sold 23,965 shares at $16.59 each, totaling $397,579.35, reducing his stake by 4.78%. He now owns 477,183 shares valued at $7,916,465.97. The sale was disclosed in an SEC filing. Schlosser previously sold shares on November 11th and September 22nd. Oscar Health's stock performance and institutional investor activities are also highlighted, along with analyst ratings and price targets.</p>

Oscar Health (NYSE:OSCR) Insider Mario Schlosser Sells 23,965 Shares of Stock